General Information

Webcast ImageWebcast
Q4 2012 Abiomed, Inc. Earnings Conference Call (Replay)
05/16/12 at 8:00 a.m. ET
Q4 2012 Abiomed, Inc. Earnings Conference Call
Wednesday, May 16, 2012 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.

Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.

More >>

Stock Quote

ABMD (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$23.10
Change (%) Stock is Down 0.12 (0.52%)
Volume532,933
Data as of 05/17/12 3:39 p.m. ET
Minimum 20 minute delay
Refresh quote
2011 Annual Report
Proxy

Recent News

More >>
DateTitle 
05/16/12Abiomed Announces Record Fourth Quarter Revenue of $37.3 Million, Up 31% and Achieves Profitability for Full Fiscal Year
DANVERS, Mass., May 16, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD - News), a leading provider of breakthrough heart support technologies, today reported fourth quarter fiscal 2012 revenue of $37.3 million, up 31% compared to revenue of $28.5 million in the same period of fiscal 2011, and GAAP net income of $2.6 million or $0.06 per diluted share compared to GAAP net loss of $1.8 million or a loss of $0.05 per basic and diluted share in the prior year. For the full fiscal year, total re... 
Printer Friendly Version
05/10/12Abiomed to Present at Bank of America Merrill Lynch 2012 Health Care Conference
DANVERS, Mass., May 10, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susie Lisa, Senior Director, Investor Relations and Corporate Development, will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Thursday, May 17, 2012 at 10:40 a.m. PDT. The conference will be held at the Encore at the Wynn Hotel, Las Vegas. ABOUT ABIOMED Based in Danvers, Massachusetts, Abiomed, Inc.... 
Printer Friendly Version
05/08/12Abiomed Announces Participation in Three Upcoming Physician Society Meetings: SCAI, HRS, & EuroPCR
DANVERS, Mass., May 8, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of break-through heart support technologies, today announced its participation in three upcoming physician society meetings: Society for Cardiovascular Angiography and Interventions (SCAI), May 9-12 in Las Vegas, Nevada – Booth 417 Heart Rhythm Society (HRS), May 9-12 in Boston, Massachusetts – Booth 1413 EuroPCR, May 15-18 in Paris, France – Booth M69 (Level 2) At all three mee... 
Printer Friendly Version
05/08/12Abiomed Fourth Quarter and Full Fiscal Year 2012 Earnings and Conference Call Notification
DANVERS, Mass., May 8, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) announced today that on Wednesday, May 16, 2012, the Company will release financial results for the fourth quarter and full year of fiscal 2012. The Company will host a conference call to discuss its results on Wednesday, May 16, 2012, at 8:00 a.m. ET. Michael R. Minogue, Chairman, President and Chief Executive Officer; Robert L. Bowen, Vice President and Chief Financial Officer; and Susan Vissers Lisa, Senior Director, ... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Minimum 20 minutes delayed